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Mycophenolic acid mediated mitochondrial membrane 
potential transition change lead to T lymphocyte 
apoptosis
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Purpose: This study demonstrated that apoptosis induced by mycophenolic acid (MPA) is mediated by mitochondrial mem-
brane potential transition (MPT) changes in Jurkat cells. Methods: Cell viability and MPT changes were measured by flow 
cytometry. Western blotting was performed to evaluate the expression of Bcl-2 family proteins, Bid, truncated Bid (tBid), cy-
tochrome c, voltage dependent anion channel (VDAC), poly ADP-ribose polymerase (PARP), and protein kinase C-δ 
(PKC-δ). The catalytic activity of caspase-9 and -3 was also measured. Results: Cell viability was decreased in time- and 
dose-dependent manners. Bcl-2 protein expression was decreased, but Bax protein expression was identified. A decreased 
Bcl-XL /Bcl-XS ratio was also noted. The expression of tBid protein also increased in a time-dependent manner in Jurkat cells 
treated with MPA. While normal MPT appeared as orange fluorescence, abnormal MPT corresponded to green fluorescence. 
Green fluorescence increased as orange decreased in the MPA-treated cells. Significantly increased concentrations of MPA 
induced the release of cytosolic cytochrome c. MPA also augmented the catalytic activity of caspase-9 and caspase-3 in Jurkat 
cells. Our findings demonstrated that MPA-induced apoptosis is mediated by MPT changes accompanied by decreased 
Bcl-XL expression and the appearance of tBid protein. The release of cytosolic cytochrome c from mitochondria and in-
creased catalytic activity of caspase-9 and caspase-3 were observed in MPA-treated Jurkat cells. Conclusion: These results 
suggest that mitochondrial dysfunction caused by MPA induces human T lymphocyte apoptosis.
Key Words: Mycophenolic acid, Mitochondrial membrane potential, Apoptosis
INTRODUCTION
Mycophenolic acid (MPA) is a selective inhibitor of en-
zymes such as inosine monophosphate dehydrogenase 
that has a role in guanosine synthesis. MPA also disrupts 
DNA synthesis in T and B lymphocytes, and suppresses 
immune functions by inducing apoptosis. However, the 
underlying signaling pathways are not known. Apoptotic 
signaling is conducted through the death receptor, mi-
tochondrial, and endoplasmic reticulum-mediated stress 
protein pathways. Key biochemical events involved in the 
induction of apoptosis include the up-regulated ex-
pression of pro-apoptotic proteins and/or down-regu-
lation of anti-apoptotic proteins. The primary apoptotic Soo Jin Na Choi, et al.
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signal transduction cascade associated with programmed 
cell death involves members of the Bcl-2 family [1]. 
Proteins belonging to the Bcl-2 family either promote cell 
survival (Bcl-2 and Bcl-XL) or induce apoptosis (Bax) [2]. 
Increased levels of Bax and/or decreases in Bcl-2 ex-
pression leads to the loss of mitochondrial membrane 
potential. This is a key event in apoptosis induction, and 
involves a reduction of ATP levels, influx of ions that de-
creases the mitochondrial membrane potential, and the 
opening of mitochondrial permeability transition pores 
[3]. Loss of mitochondrial membrane potential is cata-
strophic for cells and leads to the release of cytochrome c 
into the cytosol [3]. Mitochondrial dysfunction has been 
shown to participate in the induction of apoptosis and has 
been suggested to activate the apoptotic pathway. 
This study evaluated the mitochondrial membrane po-
tential transition (MPT) changes that lead to MPA-medi-
ated apoptosis in Jurkat cells. Cell viability and MPT 
changes were measured by flow cytometry. Western blot-
ting was performed to evaluate the expression of Bcl-2 
family proteins, Bid, tBid, cytochrome c, voltage depend-
ent anion channel (VDAC), and protein kinase C-δ (PKC- 
δ). The catalytic activity of caspase-9 and -3 in the Jurkat 
cells was also measured.
METHODS
Cell lines and culturing
Human Jurkat T cells, a T lymphocytic cell line, were ob-
tained from the Korean Collection for Type Cultures 
(KCTC, Seoul, Korea) and maintained in Roswell Park 
Memorial Institute medium (RPMI)-1640 (Gibco BRL, 
Grand Island, NY, USA) tissue culture medium supple-
mented with 10% fetal calf serum at 37
oC in 5% CO2. MPA 
(Sigma Chemical Co., St. Louis, MO, USA) was liquefied 
and dissolved at a concentration of 10 mg/mL in dime-
thylsufoxide (DMSO), stored at -20
oC, and diluted in the 
RPMI-1640 at final concentration of 0.5 to 100 M/mL.
Measurement of cell viability 
Cell viability was measured by an 3-[4,5-dimethylthia-
zol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. 
Cells seeded at 100 μL/well in a flat-bottom 24-well plate. 
The cells were incubated in a CO2 culture medium to per-
mit cell attachment for more than 3 hours and then used 
for the experiment. An MTT solution (5 mg/mL in phos-
phate-buffered saline) added at a 1/10 volume of the total 
cell culture volume. After incubating for 4 hours, 0.01 N 
HCI with 10% sodium dodecyl sulfate was added (100 μL/ 
well). After the formazan crystals formed by live cells had 
been dissolved, the absorption of each well was measured 
by an enzyme-linked immunosorbent assay plate reader 
(Molecular Devices Co., Sunnyvale, CA, USA) at 540 nm. 
Assay to measure caspase activation 
Jurkat cells were lysed with lysis buffer (1% Triton X- 
100, 0.32 M sucrose, 5 mM ethylenediaminetetraacetic acid 
(EDTA), 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 
μg/mL aprotinin, 1 μg/mL leupeptin, 2 mM dithiothreitol 
(DTT), and 10 mM Tris/HCI, pH 8.0) at 4
oC for 15 minutes, 
and then centrifuged at 20,000 × g for 15 minutes. The 
cleared lysates were then treated with bicinchroninic acid 
(BCA; Sigma Chemical Co.). 
The lysates were then incubated with a fluorogenic sub-
strate in a buffer solvent (100 mM 4-(2-hydroxyethyl)-1-pi-
perazineethanesulfonic acid [HEPES], 10% sucrose, 0.1% 
Chaps, pH 7.5, 1 mM PMSF, 1 μg/mL aprotinin, 1 μg/mL 
leupeptin, and 2 mM DTT) at 37
oC for 30 minutes, and flu-
orescence was measured with a fluorometer (Molecular 
Devices Co.). Ac-DEVD-AMC (50 μM; Calbiochem, La 
Jolla, CA, USA) was used as a fluorogenic substrate to 
measure the enzymatic activity of caspase-3. The level of 
caspase-3 activity was determined by measuring proteo-
lytic cleavage at a 380 nm excitation wavelength and 460 
nm emission wavelength. Ac-LEHD-AFC (50 μM; Calbio-
chem) was used as a fluorogenic substrate to measure the 
levels of caspase-9 activity by measuring proteolytic cleav-
age at a 400 nm excitation wavelength and 505 nm emis-
sion wavelength. 
Western blotting 
After treating Jurkat cells with MPA, the cells were col-
lected and washed twice with cold Hank's balanced salt 
solution. The cells were lysed in radioimmunoprecipi-
tation assay buffer (50 mM HEPES, pH 7.4; 150 mM NaCl, MPA mediated mitochondrial membrane potential transition
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Fig. 1. Bcl-XL/Bcl-XS ratio decreases in Jurkat cells treated with 
mycophenolic acid (mycophenolic acid [MPA]; 5 μM).  Cells were 
treated with 5 μM MPA for various periods of time. Equal amounts 
of protein from cell lysate were separated by 15% sodium dodecyl 
sulfate polyacrylamide gel electrophoresis, transferred onto 
nitrocellulose membranes, and immunoblotted with anti- Bcl-XL
and anti-Bcl-XS antibodies. 
Fig. 2. Mycophenolic acid (MPA) induces the truncated Bid (tBid) 
protein in Jurkat cells. Cells were treated with 5 μM MPA for various 
periods and separated into cytosolic and mitochondrial fractions. 
The cytosolic fraction was separated by 15% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis and immunoblotted for Bid and 
tBid. Antibody binding was visualized by enhanced chemillu-
minescence. 
1% deoxycholate, 1 mM EDTA, 1 mM PMSF, and 1 μg/mL 
aprotinin) on ice for 30 minutes. Proteins in the lysates 
were separated by electrophoresis and transferred to ni-
trocellulose membranes using a semi-dry electrotransfer 
system (Illard Co., Seattle, WA, USA) at 4
oC and 30 V for 16 
hours. The membranes were incubated in blocking buffer 
(10% skim milk) at room temperature for 2 hours, and then 
probed with antibodies against Bcl-2 family proteins, Bid, 
tBid, cytochrome c, VDAC, PARP, and PKC-δ. The blots 
were then incubated with a secondary horseradish perox-
idase-conjugated anti-rabbit immunoglobulin G (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA) at room tem-
perature for 1 hour  Immunoreactive bands were detected 
with an enhanced chemiluminescence kit  and by expos-
ing the blots to film. 
Mitochondrial membrane potential transition assay 
MPT changes were measured by flow cytometry (FACS 
Calibur, BD Bioscience, San Jose, CA, USA). Jurkat cells 
treated with MPA were stained with 10 μg/mL of JC-1 
(Molecular Probes, Eugene, OR, USA) and incubated at 
37
oC for 30 minutes.
RESULTS 
MPA decreased the viability of Jurkat cells in dose- and 
time-dependent manners. Bcl-2 protein expression de-
creased and Bax protein expression appeared following 
MPA treatment. Additionally, the Bcl-XL/Bcl-XS ratio de-
creased (Fig. 1). The level of tBid protein also increased in 
a time-dependent manner in MPA-treated Jurkat cells 
(Fig. 2). Normal MPT appears as orange fluorescence 
while green fluorescence indicates abnormal MPT. In the 
present study, green fluorescence increased while orange 
decreased in the MPA-treated cells (Fig. 3). Treatment with 
MPA also significantly increased the release of cytosolic 
cytochrome c (Fig. 4). Enzymatic activation of caspase- 3 
and -9 was measured by fluorogenic substrate to examine 
the mechanism through which apoptosis is induced by 
MPA. MPA increased the catalytic activity of both cas-
pase-3 and 9 in Jurkat cells in a time-dependent manner. 
The enzymatic activation of caspase-9 gradually increased 
after 6 hours, and reached a maximum (6.5-times greater 
than the control group) after 30 hours, but rapidly de-
creased (Fig. 5A). Activation of caspase-3 was also gradu-
ally increased (Fig. 5B). The expression of PARP and pro-
tein kinase C-δ (PKC-δ) was measured by Western blotting 
to observe the changes of substrate in the cytoplasm re-
sulting from the activation of caspase-3. A 116 kDa PARP 
band, one of caspase-3 substrates, was cleaved into a 85 
kDa band after 6 hours of MPA treatment; after 24 hours, 
more than 50% of the PARP had been cleaved. A 78 kDa 
PKC-δ, another substrate of caspase-3, was cleaved into a 
40 kDa fragment after 12 hours of MPA treatment (Fig. 5C). 
Taken together, our findings demonstrated that MPA in-
creased the catalytic activity of both caspase-9 and -3 in 
Jurkat cells. We therefore concluded that MPA-induced 
apoptosis in Jurkat cells is mediated  by changes in MPT 
and the expression of tBid  protein via cyotchrome c re-
lease and the activity of caspase-9 and -3. Thus, MPA- Soo Jin Na Choi, et al.
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Fig. 3. Mycophenolic acid induces changes in mitochondrial membrane potential transition. Cells were stained with JC-1 and analyzed using 
flow cytometry. MPT, membrane potential transition.
mediated mitochondrial dysfunction leads to human T 
lymphocyte apoptosis.
DISCUSSION 
Our study was carried out in human Jurkat cells which 
share the characteristics of human T lymphocytes and are 
a well-established model of human T cells. T lymphocytes MPA mediated mitochondrial membrane potential transition
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Fig. 4. Mycophenolic acid (MPA) induces the cytosolic release of 
cytochrome c from mitochondria in Jurkat cells. Cells were treated 
with 5 μM MPA for various periods of time. Cells were separated 
into cytosolic and mitochondrial fractions. The two fractions were 
separated by 15% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis and immunoblotted for cytochrome c and voltage 
dependent anion channel (VDAC). Immunoreactive signals were 
visualized by enhanced chemilluminescence.
are a major component of the immune system and are one 
of the few immune cells found throughout the body. MPA 
interrupts DNA synthesis in T and B lymphocytes, and 
suppresses immune function b y  i n d u c i n g  a p o p t o s i s .  
However, the signaling pathways involved in this proce-
dure are not well understood [4]. 
Apoptosis, also known as a programmed cell death, is 
one an essential physiological process involved in the 
growth of normal organs and constant maintenance of 
tissues. Hallmarks of apoptosis include cellular contrac-
tion of due to dehydration, cell membrane blebbing, in-
creased cytoplasmic calcium concentration, chromatin 
condensation, DNA fragmentation in a characteristic 
“ladder pattern” due to activated endonucleases, and 
apoptotic body formation [5].
The major apoptotic signal transduction cascade in-
volves the Bcl-2 family proteins [6]. Bcl-2 is a protein asso-
ciated with human follicular lymphoma with a molecular 
weight of 28 kDa. It is not involved in the cellular growth, 
but acts to suppress apoptosis. The mechanism by which 
Bcl-2 prevents apoptosis is known to play a role in control-
ling the integrity of the outer mitochondrial membrane. A 
Fig. 5. Mycophenolic acid (MPA) increases the catalytic 
activity of caspase-9 and -3 of Jurkat cells in a time-dependent 
manner. Cells were treated with 5 μM MPA for various periods 
of time and then lysed to measure the activity of these 
proteases using fluorogenic biosubstrates. The lysate were 
incubated with Ac-LEHD-AFC to examine caspase-9 (A) or 
Ac-DEVD-AMC to monitor caspase-3 (B). Protein kinase C-δ 
(PKC-δ) cleavage was measured by Western blotting with an 
anti-PKC-δ antibody (C). 
a)P ＜ 0.05 by student t-test, com-
pared to control group.Soo Jin Na Choi, et al.
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previous study concluded that the decreased ratio of Bcl- 
XL/Bcl-XS by MPA directly correlated with apoptosis in 
Jurkat cells [7]. Bcl-2 degradation was observed when cell 
viability reduced below 20% (40 hours after MPA treat-
ment). In contrast to Bcl-2, Bax is known to promote apop-
tosis [8]. Expression of Bax was also observed. Thus, our 
study showed that the expression of Bcl-2 and Bax had op-
posing effects on apoptosis in Jurkat cells treated with 
MPA.  Increases in the level of Bax and/or decreased Bcl-2 
expression leads to loss of mitochondrial membrane po-
tential which is a key event in the induction of apoptosis. 
This process involves a reduction in ATP levels, influx of 
ions that leads to decreased mitochondrial membrane po-
tential, and opening of the mitochondrial permeability 
transition pores [7].
Bid is one of proapoptotic Bcl-2 homology (BH) 3 only 
proteins. BH3 only proteins promote mitochondrial outer 
membrane permealization and essential for apoptosis 
initiation. BH3 only proteins bind with high affinity and 
specificity to anti-apoptotic Bcl-2 family member, thereby 
Bax/Bak to elicit mitochondrial outer membrane permeali-
zation and activation of caspase cascade [9,10]. tBid targets 
the mitochondria causing leakage of apoptogenic pro-
teins.  Loss of mitochondrial membrane potential is cata-
strophic for cells and leads to release of cytochrome c into 
the cytosol [11]. As the level of cytochrome c increases in 
the cytosol, it interacts with Apaf-1. ATP then forms a com-
plex with procaspase-9, leading to activation of caspase-9 
and -3 which results in PARP cleavage [12,13].
Activated caspase-3 cleaves various target protein such 
as PARP, PKC-δ, lamin, mitogen-activated protein/ex-
tracullular signal-regulated kinase, and other caspases. 
Caspase-3 is central role of apoptosis. It also induces the 
functional activation or inactivation of the molecular pro-
teins in cellular signaling pathway [14-16]. Our results 
showed that apoptosis in Jurkat cells treated with MPA 
was accompanied by activation of caspase-3 and -9 (Fig. 
5A, B). The enzymatic activation's increase of caspase-3 
and 9 and fragmentation of PARP and PKC-δ (Fig. 5C) 
were also identified. In summary, we found that MPA-in-
duced apoptosis in Jurkat cells is mediated  by MPT 
changes and the expression of tBid via cyotchrome c re-
lease and the catalytic activity of caspase-9 and 3. This re-
sult suggests that MPA causes mitochondrial dysfunction 
that leads to human T lymphocyte apoptosis [17-19].
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article 
was reported.
ACKNOWLEDGEMENTS
This study was financially supported in 2006 by 
Chonnam National University.
REFERENCES
1. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family 
members and the mitochondria in apoptosis. Genes Dev 
1999;13:1899-911.
2 .H o c k e n b e r y  D ,  N u ñ e z  G ,  Milliman C, Schreiber RD, 
Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane 
protein that blocks programmed cell death. Nature 1990; 
348:334-6.
3. Crompton M. Bax, Bid and the permeabilization of the mi-
tochondrial outer membrane in apoptosis. Curr Opin Cell 
Biol 2000;12:414-9.
4. Lee WA, Gu L, Miksztal AR, Chu N, Leung K, Nelson PH. 
Bioavailability improvement of mycophenolic acid through 
amino ester derivatization. Pharm Res 1990;7:161-6.
5. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter 
ME. Apoptosis signaling by death receptors. Eur J 
Biochem 1998;254:439-59.
6. Cory S, Adams JM. The Bcl2 family: regulators of the cel-
lular life-or-death switch. Nat Rev Cancer 2002;2:647-56. 
7. Vander Heiden MG, Chandel NS, Williamson EK, Schu-
macker PT, Thompson CB. Bcl-xL regulates the membrane 
potential and volume homeostasis of mitochondria. Cell 
1997;91:627-37.
8. Annis MG, Soucie EL, Dlugosz PJ, Cruz-Aguado JA, Penn 
LZ, Leber B, et al. Bax forms multispanning monomers 
that oligomerize to permeabilize membranes during apop-
tosis. EMBO J 2005;24:2096-103.
9. Huang DC, Strasser A. BH3-Only proteins-essential ini-
tiators of apoptotic cell death. Cell 2000;103:839-42.
10. Lee YC, Kim JJ, Park HR, Lee S, Woo YM, Cho MH, et al. A 
study for apoptosis and its mechanism of allogeneic acti-
vated T lymphocytes induced by mouse liver immature 
dendritic cells. J Korean Surg Soc 2004;66:1-4. 
11. Li PF, Dietz R, von Harsdorf R. p53 regulates mitochon-MPA mediated mitochondrial membrane potential transition
thesurgery.or.kr 241
drial membrane potential through reactive oxygen species 
and induces cytochrome c-independent apoptosis blocked 
by Bcl-2. EMBO J 1999;18:6027-36.
12. Desagher S, Martinou JC. Mitochondria as the central con-
trol point of apoptosis. Trends Cell Biol 2000;10:369-77.
13. Gogvadze V, Orrenius S, Zhivotovsky B. Multiple path-
ways of cytochrome c release from mitochondria in apop-
tosis. Biochim Biophys Acta 2006;1757:639-47.
14. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, 
Okazaki T, et al. Caspases are activated in a branched pro-
tease cascade and control distinct downstream processes in 
Fas-induced apoptosis. J Exp Med 1998;187:587-600.
15. Creagh EM, Martin SJ. Caspases: cellular demolition 
experts. Biochem Soc Trans 2001;29(Pt 6):696-702.
16. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochem-
ical pathways of caspase activation during apoptosis. 
Annu Rev Cell Dev Biol 1999;15:269-90.
17. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, 
Brothers GM, et al. Molecular characterization of mi-
tochondrial apoptosis-inducing factor. Nature 1999;397: 
441-6.
18. Green DR, Reed JC. Mitochondria and apoptosis. Science 
1998;281:1309-12.
19. Ly JD, Grubb DR, Lawen A. The mitochondrial membrane 
potential (deltapsi(m)) in apoptosis; an update. Apoptosis 
2003;8:115-28.